Back to Search
Start Over
Updated results of the PRIMA study confirms the benefit of 2-years rituximab maintenance in follicular lymphoma patients responding to immunochemotheraphy
- Source :
- Salles, GA, Catalano, J, Feugier, P, Offner, FC, Bouabdallah, R, Caballero, D, Brice, P, Pedersen, L M, Haioun, C, Belada, D, Delmer, A, Simpson, D, Tilly, H, Leppa, S, Soubeyran, P, Hagenbeek, A, Casasnovas, O, Intragumtornchai, T, Fermé, C, Gomes de Silva, M, Sebban, C, Lister, A, Esrell, JA, Milone, G, Sonet, A, Lopez-Guillermo, A & Seymour, JF 2010, ' Updated results of the PRIMA study confirms the benefit of 2-years rituximab maintenance in follicular lymphoma patients responding to immunochemotheraphy ', Blood, vol. 116, pp. 746 .
- Publication Year :
- 2010
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Salles, GA, Catalano, J, Feugier, P, Offner, FC, Bouabdallah, R, Caballero, D, Brice, P, Pedersen, L M, Haioun, C, Belada, D, Delmer, A, Simpson, D, Tilly, H, Leppa, S, Soubeyran, P, Hagenbeek, A, Casasnovas, O, Intragumtornchai, T, Fermé, C, Gomes de Silva, M, Sebban, C, Lister, A, Esrell, JA, Milone, G, Sonet, A, Lopez-Guillermo, A & Seymour, JF 2010, ' Updated results of the PRIMA study confirms the benefit of 2-years rituximab maintenance in follicular lymphoma patients responding to immunochemotheraphy ', Blood, vol. 116, pp. 746 .
- Accession number :
- edsair.od......3062..1f68f1897d9e82d509c339afcf7bb01d